Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Optimi HealthOPTH +1.01%24 EV-to-OCF is -13.86 as of Jul. 19, 2026. GuruFocus rates OPTH with a GF Score™ of 24/100 and a GF Value™ of $4.32 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Optimi Health ranks better than 84.91% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Optimi Health's Enterprise Value is $32.29 Mil.
Optimi Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-2.33 Mil. Therefore, Optimi Health's EV-to-OCF for today is -13.86.
The historical rank and industry rank for Optimi Health's EV-to-OCF or its related term are showing as below:
OPTH'
s EV-to-OCF Range Over the Past 10 Years
Min: -17.4 Med: -6.54 Max: -1.49
Current: -14.3
During the past 6 years, the highest EV-to-OCF of Optimi Health was -1.49. The lowest was -17.40. And the median was -6.54.
OPTH's EV-to-OCF is ranked better than 84.91% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 10.55
vs OPTH: -14.30
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Optimi Health's PE Ratio (TTM) for today is calculated as:
Optimi Health's share price for today is $5.01.
Optimi Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.445.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Optimi Health EV-to-OCF Related Terms
Optimi Health EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Optimi Health's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Optimi Health's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Optimi Health EV-to-OCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Optimi Health's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Optimi Health's EV-to-OCF falls into.
Optimi Health's current Enterprise Value is $32.29 Mil.
Optimi Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.33 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Optimi Health (OPTH) has a EV-to-OCF of -13.86 as of Jul. 19, 2026. According to the industry distribution chart, Optimi Health ranks #152 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 15.1%.
Is Optimi Health's EV-to-OCF too high?
Optimi Health's current EV-to-OCF is -13.86. Based on the distribution chart, Optimi Health ranks #152 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Optimi Health has a GF Score™ of 24/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Optimi Health's EV-to-OCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Optimi Health ranks #152 out of 1007 companies for EV-to-OCF. This places Optimi Health in the top 15% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 10.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Drug Manufacturers company?
The median EV-to-OCF among Drug Manufacturers companies is 10.55, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median EV-to-OCF is 10.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Optimi Health's current EV-to-OCF is -13.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Optimi Health stock overvalued right now?
Based on GuruFocus' analysis, Optimi Health (OPTH) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.32, compared to a current price of $5.01 — trading 16% above its estimated fair value. The current EV-to-OCF is -13.86. Optimi Health's overall GF Score™ is 24/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Optimi Health (OPTH), the current EV-to-OCF is -13.86 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Optimi Health (OPTH) Overvalued in 2026?
Based on GuruFocus' analysis, Optimi Health stock appears to be overvalued.
The current stock price of $5.01 is trading 16% above its estimated GF Value™ of $4.32.
GuruFocus considers Optimi Health to be Modestly Overvalued.
Key valuation signals for OPTH:
EV-to-OCF: -13.86
GF Value™: $4.32 vs. price of $5.01 (16% above fair value)
No single metric tells the full story. See the OPTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
24GF Score
Get the complete analysis for OPTH
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OPTH has been successfully added to your 
